Skip to main content
Erschienen in: World Journal of Urology 2/2014

01.04.2014 | Original Article

Prostate biopsy: results and advantages of the transperineal approach—twenty-year experience of a single center

verfasst von: Pietro Pepe, Francesco Aragona

Erschienen in: World Journal of Urology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Detection rate for prostate cancer (PCa) and complications following transperineal prostate biopsy (TPBx) were reported.

Methods

From January 1991 to December 2012, 4,000 men underwent TPBx; from 1991 to 2001, the patients underwent biopsy for suspicious DRE or PSA values >4 ng/mL; moreover, from 2002, the indications were abnormal DRE, PSA >10 ng/mL, PSA values between 4.1 and 10, 2.6 and 4 and <2.5 ng/mL with F/T PSA <25, <20 <15 %, respectively. In case of initial biopsy, the number of needles cores increased from 6 (1991–1996) to 12 (1997–2012) and 18 cores (2002–2012); in case of repeat biopsy, since 2005 a saturation biopsy (SPBx) with >24 cores was performed.

Results

Overall, PCa, normal parenchyma, HGPIN and ASAP were found in 1,379 (34.5 %), 2,400 (60 %), 175 (4.4 %) and 46 (1.1 %) patients, respectively; in case of initial TPBx, the scheme at 18 showed a greater PCa detection in comparison with scheme at 6–12 cores (p < 0.05). In case of repeat biopsy, a higher detection of microfocus of cancer was found performing a SPBx; moreover, 15 % of cancers were localized in the anterior zone. Incidence of hemospermia and urinary retention were correlated with the number of needle cores resulting equal to 30.4 versus 11.1 % in case of SPBx (p < 0.05); moreover, none developed sepsis.

Conclusions

Transperineal prostate biopsy (TPBx) resets the risk of sepsis; moreover, in case of repeat SPBx, the transperineal approach detects a high number of significant PCa localized in the anterior zone (15 % of the cases).
Literatur
1.
Zurück zum Zitat Center MM, Jemal A, Lortet-Tieulent J et al (2012) International variation in prostate cancer incidence and mortality rates. Eur Urol 61:1079–1092PubMedCrossRef Center MM, Jemal A, Lortet-Tieulent J et al (2012) International variation in prostate cancer incidence and mortality rates. Eur Urol 61:1079–1092PubMedCrossRef
2.
Zurück zum Zitat Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:765–781PubMedCrossRef Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:765–781PubMedCrossRef
3.
Zurück zum Zitat Nam RK, Saskin R, Lee Y et al (2010) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 183:963–969PubMedCrossRef Nam RK, Saskin R, Lee Y et al (2010) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 183:963–969PubMedCrossRef
4.
Zurück zum Zitat Hossack T, Patel MI, Huo A et al (2012) Location and pathological characteristics of cancers in radical prostatectomy specimens identified by transperineal biopsy compared to transrectal biopsy. J Urol 188:781–785PubMedCrossRef Hossack T, Patel MI, Huo A et al (2012) Location and pathological characteristics of cancers in radical prostatectomy specimens identified by transperineal biopsy compared to transrectal biopsy. J Urol 188:781–785PubMedCrossRef
5.
Zurück zum Zitat Mabjeesh NJ, Lidawi G, Chen J et al (2012) High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy. BJU Int 110:993–997PubMedCrossRef Mabjeesh NJ, Lidawi G, Chen J et al (2012) High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy. BJU Int 110:993–997PubMedCrossRef
6.
Zurück zum Zitat Bittner N, Merrick GS, Butler WM, et al (2013) Incidence And Pathologic Features Of Prostate Cancer Detected On Transperineal Template-Guided Mapping Biopsy Following Negative Transrectal Ultrasound-Guided Biopsy. J Urol (13)00290–295: pii: S0022-5347. doi:10.1016/j.juro.2013.02.021. [Epub ahead of print] Bittner N, Merrick GS, Butler WM, et al (2013) Incidence And Pathologic Features Of Prostate Cancer Detected On Transperineal Template-Guided Mapping Biopsy Following Negative Transrectal Ultrasound-Guided Biopsy. J Urol (13)00290–295: pii: S0022-5347. doi:10.​1016/​j.​juro.​2013.​02.​021. [Epub ahead of print]
7.
Zurück zum Zitat Pepe P, Aragona F (2010) Incidence of insignificant prostate cancer using free/total PSA: results of a case-finding protocol on 14,453 patients. Prostate Cancer Prostatic Dis 13:316–319PubMedCrossRef Pepe P, Aragona F (2010) Incidence of insignificant prostate cancer using free/total PSA: results of a case-finding protocol on 14,453 patients. Prostate Cancer Prostatic Dis 13:316–319PubMedCrossRef
8.
Zurück zum Zitat Pepe P, Aragona F (2005) Prostate needle biopsy: 12 vs 18 cores. Is it necessary? Urol Int 75:19–22CrossRef Pepe P, Aragona F (2005) Prostate needle biopsy: 12 vs 18 cores. Is it necessary? Urol Int 75:19–22CrossRef
9.
Zurück zum Zitat Pepe P, Aragona F (2007) Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation. Urology 70:1131–1135PubMedCrossRef Pepe P, Aragona F (2007) Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation. Urology 70:1131–1135PubMedCrossRef
10.
Zurück zum Zitat Hodge KK, McNeal JE, Terris MK et al (1989) Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142:71–75PubMed Hodge KK, McNeal JE, Terris MK et al (1989) Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142:71–75PubMed
11.
Zurück zum Zitat Ravery V, Goldblatt L, Royer B et al (2000) Extensive biopsy protocol improves the detection rate of prostate cancer. J Urol 164:393–396PubMedCrossRef Ravery V, Goldblatt L, Royer B et al (2000) Extensive biopsy protocol improves the detection rate of prostate cancer. J Urol 164:393–396PubMedCrossRef
12.
Zurück zum Zitat Lee AK, Doytchinova T, Chen M et al (2003) Can the core length involved with prostate cancer identify clinically insignificant disease in low risk patients diagnosed on the basis of a single positive core ? Urol Oncol 21:123–127PubMedCrossRef Lee AK, Doytchinova T, Chen M et al (2003) Can the core length involved with prostate cancer identify clinically insignificant disease in low risk patients diagnosed on the basis of a single positive core ? Urol Oncol 21:123–127PubMedCrossRef
13.
Zurück zum Zitat Okimura O, Coleman JA, de la Taille A et al (2013) Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care. Eur Urol 63:214–230CrossRef Okimura O, Coleman JA, de la Taille A et al (2013) Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care. Eur Urol 63:214–230CrossRef
14.
Zurück zum Zitat Pepe P, Garufi A, Priolo G et al (2013) Prostate cancer detection at repeat biopsy: can pelvic phased-array multiparametric MRI replace saturation biopsy? Anticancer Res 33:1195–1199PubMed Pepe P, Garufi A, Priolo G et al (2013) Prostate cancer detection at repeat biopsy: can pelvic phased-array multiparametric MRI replace saturation biopsy? Anticancer Res 33:1195–1199PubMed
15.
Zurück zum Zitat Pinto PA, Chung PH, Rastinehad AR et al (2011) Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J Urol 186:1281–1285PubMedCentralPubMedCrossRef Pinto PA, Chung PH, Rastinehad AR et al (2011) Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J Urol 186:1281–1285PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Kawakami S, Yamamoto S, Numao N et al (2007) Direct comparison between transrectal and transperineal extended prostate biopsy for the detection of cancer. Int J Urol 14:719–724PubMedCrossRef Kawakami S, Yamamoto S, Numao N et al (2007) Direct comparison between transrectal and transperineal extended prostate biopsy for the detection of cancer. Int J Urol 14:719–724PubMedCrossRef
17.
Zurück zum Zitat Shen PF, Zhu YC, Wei WR et al (2012) The results of transperineal versus transrectal prostate biopsy: a systematic review and meta-analysis. Asian J Androl 14:310–315PubMedCentralPubMedCrossRef Shen PF, Zhu YC, Wei WR et al (2012) The results of transperineal versus transrectal prostate biopsy: a systematic review and meta-analysis. Asian J Androl 14:310–315PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Abdollah F, Novara G, Briganti A et al (2011) Trans-rectal versus trans-perineal saturation rebiopsy of the prostate: is there a difference in cancer detection rate? Urology 77:921–925PubMedCrossRef Abdollah F, Novara G, Briganti A et al (2011) Trans-rectal versus trans-perineal saturation rebiopsy of the prostate: is there a difference in cancer detection rate? Urology 77:921–925PubMedCrossRef
19.
Zurück zum Zitat Taira AV, Merrick GS, Galbreath RW et al (2010) Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting. Prostate Cancer Prostatic Dis. 13:71–77PubMedCentralPubMedCrossRef Taira AV, Merrick GS, Galbreath RW et al (2010) Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting. Prostate Cancer Prostatic Dis. 13:71–77PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Mabjeesh NJ, Lidawi G, Chen J et al (2012) High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy. BJU Int 110:993–997PubMedCrossRef Mabjeesh NJ, Lidawi G, Chen J et al (2012) High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy. BJU Int 110:993–997PubMedCrossRef
21.
Zurück zum Zitat Dimmen M, Vlatkovic L, Hole KH et al (2012) Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies. BJU Int 110:69–75CrossRef Dimmen M, Vlatkovic L, Hole KH et al (2012) Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies. BJU Int 110:69–75CrossRef
22.
Zurück zum Zitat Hossack T, Patel MI, Huo A et al (2012) Location and pathological characteristics of cancers in radical prostatectomy specimens identified by transperineal biopsy compared to transrectal biopsy. J Urol 188:781–785PubMedCrossRef Hossack T, Patel MI, Huo A et al (2012) Location and pathological characteristics of cancers in radical prostatectomy specimens identified by transperineal biopsy compared to transrectal biopsy. J Urol 188:781–785PubMedCrossRef
23.
Zurück zum Zitat Ayres BE, Montgomery BS, Barber NJ et al (2012) The role of transperineal template prostate biopsies in restaging men with prostate cancer managed by active surveillance. BJU Int 109:1170–1176PubMedCrossRef Ayres BE, Montgomery BS, Barber NJ et al (2012) The role of transperineal template prostate biopsies in restaging men with prostate cancer managed by active surveillance. BJU Int 109:1170–1176PubMedCrossRef
24.
Zurück zum Zitat Barzell WE, Melamed MR, Cathcart P et al (2012) Identifying candidates for active surveillance: an evaluation of the repeat biopsy strategy for men with favorable risk prostate cancer. J Urol 188:762–767PubMedCrossRef Barzell WE, Melamed MR, Cathcart P et al (2012) Identifying candidates for active surveillance: an evaluation of the repeat biopsy strategy for men with favorable risk prostate cancer. J Urol 188:762–767PubMedCrossRef
25.
Zurück zum Zitat Epstein J, Walsh P, Carmichael M (1994) Pathological and clinical findings to predict tumor extent of non palpable (stage T1c) prostate cancer. JAMA 271:368–374PubMedCrossRef Epstein J, Walsh P, Carmichael M (1994) Pathological and clinical findings to predict tumor extent of non palpable (stage T1c) prostate cancer. JAMA 271:368–374PubMedCrossRef
26.
Zurück zum Zitat Nam RK, Saskin R, Lee Y et al (2010) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 183:963–969PubMedCrossRef Nam RK, Saskin R, Lee Y et al (2010) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 183:963–969PubMedCrossRef
27.
Zurück zum Zitat Loeb B, Carter HB, Berndt SI et al (2011) Complications after prostate biopsy: data from SEE-Medicare. J Urol 186:1830–1834PubMedCrossRef Loeb B, Carter HB, Berndt SI et al (2011) Complications after prostate biopsy: data from SEE-Medicare. J Urol 186:1830–1834PubMedCrossRef
28.
Zurück zum Zitat Loeb B, Carter HB, Berndt SI et al (2013) Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare. J Urol 189:867–870PubMedCrossRef Loeb B, Carter HB, Berndt SI et al (2013) Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare. J Urol 189:867–870PubMedCrossRef
29.
Zurück zum Zitat Miller J, Perumalla C, Heap G (2005) Complications of transrectal versus transperineal prostate biopsy. ANZ J Surg 75:48–50PubMedCrossRef Miller J, Perumalla C, Heap G (2005) Complications of transrectal versus transperineal prostate biopsy. ANZ J Surg 75:48–50PubMedCrossRef
30.
Zurück zum Zitat Kepner GR, Kepner JV (2010) Transperineale prostate biopsy: analysis of a uniform core sampling pattern that yields data on tumor volume limits in negative biopsies. Theor Biol Med Model 7:23–36PubMedCentralPubMedCrossRef Kepner GR, Kepner JV (2010) Transperineale prostate biopsy: analysis of a uniform core sampling pattern that yields data on tumor volume limits in negative biopsies. Theor Biol Med Model 7:23–36PubMedCentralPubMedCrossRef
Metadaten
Titel
Prostate biopsy: results and advantages of the transperineal approach—twenty-year experience of a single center
verfasst von
Pietro Pepe
Francesco Aragona
Publikationsdatum
01.04.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 2/2014
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-013-1108-1

Weitere Artikel der Ausgabe 2/2014

World Journal of Urology 2/2014 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.